Intraosseous administration of antidotes - a systematic review.
Audrée ElliottPierre-André DubéAmélie Cossette-CôtéLaura PatakfalviEric VilleneuveMartin MorrisSophie GosselinPublished in: Clinical toxicology (Philadelphia, Pa.) (2017)
The evidence supporting the use of IO route for the administration of antidotes in a context of poisoning is scarce. The majority of the evidence consists of case reports and animal experiments. Common antidotes such as acetylcysteine, fomepizole, and digoxin-specific antibody fragments have not been studied or reported with the use of the IO route. Despite the low-quality evidence available, IO access is a potential option for antidotal treatments in toxicological resuscitation when IV access is unavailable.